CSF1R and central nervous system cancer: These glioma‐supplied cytokines were also responsible for changing the transcriptomic profile of surviving TAMs, reprogramming them toward a less pro‐tumoral phenotype by reducing the polarization of M2 macrophages in gliomas treated with CSF‐1R inhibitor.